wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36145795-480B4F55-99C3-4760-9C7E-FE50DDEF33FD
Q36145795-480B4F55-99C3-4760-9C7E-FE50DDEF33FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36145795-480B4F55-99C3-4760-9C7E-FE50DDEF33FD
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
P2860
Q36145795-480B4F55-99C3-4760-9C7E-FE50DDEF33FD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36145795-480B4F55-99C3-4760-9C7E-FE50DDEF33FD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3882f7616d1bfbc2b27d0d8fb56ba08978328727
P2860
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.